Permira proposes to take Cambrex private in $2.4B deal, stirring up CDMO M&A
Cambrex is at the M&A game again, but this time it’s switching roles. After buying out Halo Pharma and Avista Pharma Solutions in the past …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
